Vimarsana
Biggest News Aggregation in the World

Eric Zi News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Eric Zi. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Eric Zi Today - Breaking & Trending Today

VenusP-Valve granted IDE approval for clinical trial, unveiling a new chapter for Chinese valve solutions globally - Vimarsana News

VenusP-Valve granted IDE approval for clinical trial, unveiling a new chapter for Chinese valve solutions globally

Recently, Venus Medtech (Hangzhou) Inc. ("Venus Medtech"), a leading provider of integrated solutions for transcatheter structural heart valvular therapies in China, announced the Investigational Device Exemption (IDE) full approval for its in-house developed VenusP-Valve from the U.S. Food and Drug Administration (FDA). VenusP-Valve, thus, has become the first China-developed heart valvular system to be approved by the FDA for clinical trial, setting a new milestone in the global footprint of C

Source: yahoo.com
Confirmatory clinical trial of Liwen RF™ ablation system in China concluded - Vimarsana News

Confirmatory clinical trial of Liwen RF™ ablation system in China concluded

/PRNewswire/ -- On March 3, Venus Medtech (Hangzhou) Inc. (Venus Medtech, 2500.HK), trailblazer in structural heart therapies worldwide, announced that the...

Venus Medtech (Hangzhou) Inc.: Confirmatory clinical trial of Liwen RF ablation system in China concluded - Vimarsana News

Venus Medtech (Hangzhou) Inc.: Confirmatory clinical trial of Liwen RF ablation system in China concluded

HANGZHOU, China, March 4, 2023 /PRNewswire/ -- On March 3, Venus Medtech (Hangzhou) Inc. (Venus Medtech, 2500.HK), trailblazer in structural heart therapies worldwide, announced that the Liwen

Venus Medtech (Hangzhou) Inc.: Venus Medtech announces 2022 interim results: quality and efficiency improvement, profitability focus, rapid progress in global presence - Vimarsana News

Venus Medtech (Hangzhou) Inc.: Venus Medtech announces 2022 interim results: quality and efficiency improvement, profitability focus, rapid progress in global presence

HANGZHOU, China, Sept. 1, 2022 /PRNewswire/ -- On August 31, 2022, Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as "Venus Medtech"), a leading provider of integrated solutions

Venus Medtech announces 2022 interim results: quality and efficiency improvement, profitability focus, rapid progress in global presence - Vimarsana News

Venus Medtech announces 2022 interim results: quality and efficiency improvement, profitability focus, rapid progress in global presence

/PRNewswire/ -- On August 31, 2022, Venus Medtech (Hangzhou) Inc. (2500.HK, hereinafter referred to as "Venus Medtech"), a leading provider of integrated...